Mineralys Therapeutics (MLYS) Market Cap

Price: $13.53
Market Cap: $849.48M
Avg Volume: 975.42K
Country: US
Industry: Biotechnology
Sector: Healthcare
Beta: 1.51
52W Range: $8.241-18.38
Website: Mineralys Therapeutics

Market Cap Overview

Market Cap

$849.48M

Share Price

$13.53

Shares Outstanding

62.78M


What is Mineralys Therapeutics's Market Cap?

Mineralys Therapeutics's current Market Cap as of today is $849.48M.

Understanding Market Capitalization

Market Capitalization (Market Cap) is the total value of a company's outstanding shares of stock. It is calculated by multiplying the current market price of one share by the total number of outstanding shares.

  • It provides a straightforward method of gauging a company's size.
  • Market Cap can be used to compare companies within the same industry.

How is Market Cap calculated?

Market Cap is calculated by multiplying the current share price by the total number of outstanding shares:

Market Cap = Current Share Price × Total Shares Outstanding

In the case of Mineralys Therapeutics, the market cap is calculated as $13.53 x 62.78M shares = $849.48M.

As a Small Cap company, Mineralys Therapeutics is a smaller company that may offer growth opportunities.

Mineralys Therapeutics Historical Market Cap

$1.00B$1.00B$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00MMarket CapMar '23Mar '23May '23May '23Jul '23Jul '23Sep '23Sep '23Nov '23Nov '2320242024Feb '24Feb '24Apr '24Apr '24Jun '24Jun '24Aug '24Aug '24Oct '24Oct '24Dec '24Dec '24Feb '25Feb '25
Download SVG
Download PNG
Download CSV

Mineralys Therapeutics Market Cap vs Enterprise Value

Understanding Market Cap vs. Enterprise Value

While market cap represents the equity value of Mineralys Therapeutics, enterprise value provides a more complete picture of the company's total value by including debt and cash:

Market Cap
Enterprise Value
$800.00M$800.00M$600.00M$600.00M$400.00M$400.00M$200.00M$200.00M$0.00$0.00-$200.00M-$200.00MValue20222022Jul '22Jul '2220232023Jul '23Jul '2320242024Jul '24Jul '2420252025
Download SVG
Download PNG
Download CSV

Enterprise Value = Market Cap + Total Debt - Cash and Equivalents

Mineralys Therapeutics's enterprise value as of December 31, 2024 (Q4 2024) is calculated as:

  • Market Cap: $849.48M
  • Total Debt: $-
  • Cash and Equivalents: $114.09M
  • Enterprise Value: $500.89M

The difference between market cap and enterprise value can indicate the company's financial leverage and cash position. A lower enterprise value indicates a strong net cash position.

Mineralys Therapeutics Annual Market Cap History

Year Market Cap Change
2025 $849.48M 42.17%
2024 $597.52M 92.00%
2023 $311.22M -58.69%
2022 $753.40M 4.61%
2021 $720.20M 0.00%
2020 $720.20M N/A

Frequently Asked Questions

Mineralys Therapeutics's current market capitalization is $849.48M. This makes it a Small Cap company, calculated by multiplying its current stock price of $13.53 by 62.78M outstanding shares.

Mineralys Therapeutics's enterprise value is $500.89M. This is calculated by adding total debt ($-) to market cap and subtracting cash and equivalents ($114.09M). Enterprise value provides a more complete picture of the company's total value by considering both its debt and cash positions.

Mineralys Therapeutics has 62.78M shares outstanding. This number represents the total number of shares currently held by all shareholders, including company insiders, institutional investors, and the public.

Mineralys Therapeutics is classified as a Small Cap company. Small-cap companies are smaller companies with market caps between $300 million and $2 billion.

Mineralys Therapeutics's market cap is calculated by multiplying its current stock price ($13.53) by its total number of outstanding shares (62.78M). This calculation represents the total market value of all the company's outstanding shares at the current market price.

Related Metrics

Explore detailed financial metrics and analysis for MLYS.

Financial Analysis
Financial Statements Stock Forecast Price Target Technical Analysis Stock Splits Employee Count
Company Intelligence
Ownership Insider Trading SEC Filings Congress Trading News Earnings Call Transcripts
Income & Revenue
Earnings Revenue Revenue Growth Profit Net Income Profit Margin EBITDA Free Cash Flow Revenue Segments
Valuation
Valuation Market Cap Enterprise Value P/E Ratio PEG Ratio P/S Ratio P/B Ratio Book Value
Returns & Ratios
ROIC ROE ROA Current Ratio Quick Ratio Debt/Equity Ratio Earnings Per Share
Balance Sheet
Assets Debt Cash On Hand Shares Outstanding
Dividends
Dividends Dividend Yield Payout Ratio